Information sur le laboratoire

Alain Bitton (M.D.)

Chercheur
Unité de recherche clinique
Département de médecine (McGill)

Profil de recherche

 Fondamentale: 0%
 Clinique: 100%
 Épidémiologique: 0%
 Évaluative: 0%
 Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

Mots-clés

Maladie de Crohn • colite ulcéreuse • psychosocial • biomarqueurs biologiques • génétique

Membre de l'équipe

Nom Poste

Dernières publications

  1. Mu, K., Xue, M., Huynh, H. Q., Griffiths, A. M., Turner, D., Moayyedi, P., Steinhart, A. H., Dieleman, L. A., Deslandres, C., Bitton, A., Mack, D. R., Jacobson, K., Cino, M., Aumais, G., Panaccione, R., Bressler, B., Lee, S.-H., Turpin, W., Croitoru, K. & Crohn's and Colitis Canada Genetics Environment Microbial Project Research Consortium (2026). Serum thiol redox-related alterations in asymptomatic first-degree relatives are associated with future Crohn's disease. Redox biology, vol. 94, p. 104207.
  2. Nadeem, H., Alsaeid, M., Bitton, A., Nadeem, H. & Lakatos, P. L. (2026). Extensive Colonic Pseudopolyposis Leading to Protein-Losing Enteropathy and Severe Hypoalbuminemia With Refractory Ulcerative Colitis. ACG case reports journal, vol. 13, p. e02011.
  3. Bernstein, C. N., Nugent, Z., Panaccione, R., Marshall, D. A., Kaplan, G. G., Vanner, S., Dieleman, L. A., Graff, L. A., Otley, A., Jones, J., Buresi, M., Murthy, S., Borgaonkar, M., Bressler, B., Bitton, A., Croitoru, K., Sidani, S., Fernandes, A. & Moayyedi, P. (2026). Patient-reported Symptoms Are Independent of Extent of Disease in Longstanding Ulcerative Colitis: Magic in Imagine. Journal of clinical gastroenterology, vol. 60, p. 442-448.
  4. Kritzinger, J., Candel, I., Kotrri, G., Nadeem, H., Afif, W., Bitton, A., Wild, G., Bessissow, T. & Lakatos, P. L. (2025). Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease. World journal of gastroenterology, vol. 31, p. 114355.
  5. Gettler, K., Nagpal, S., Washburn, S., Tastad, C., Zhang, J., Sabic, K., Lazarev, M., Bitton, A., Cohen, R., Schwartz, M. B., Barrie, A., Gu, P., Fleshner, P., Bao, M., Hernández-Rocha, C., McCauley, J., Abreu, M., Kugathasan, S., McGovern, D. P., Brant, S. R., Duerr, R. H., Silverberg, M. S., Rioux, J. D., Gibson, G. & Cho, J. H. (2026). Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence. Gastroenterology, vol. 170, p. 511-522.
  6. Ongay, J., Candel, I., Bitton, A., Afif, W., Bessissow, T. & Lakatos, P. L. (2025). Case Report: Secukinumab (Interleukin-17 Inhibitor) and Ulcerative Colitis Flare - the Double-Edged Sword. Case reports in gastroenterology, vol. 19, p. 637-643.
  7. Drügg Hahn, G., Lakatos, P. L., Maedler-Kron, C., Marcus, V., Afif, W., Wild, G., Bitton, A., Flores, C., de Magalhães Francesconi, C. F. & Bessissow, T. (2025). Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis. Inflammatory bowel diseases, vol. 31, p. 2977-2985.
  8. Xue, M., Lee, S.-H., Shao, J., Leibovitzh, H., Huynh, H. Q., Griffiths, A. M., Turner, D., Madsen, K. L., Moayyedi, P., Steinhart, A. H., Silverberg, M. S., Deslandres, C., Bitton, A., Mack, D. R., Jacobson, K., Ropeleski, M. J., Cino, M., Aumais, G., Bernstein, C. N., Panaccione, R., Bressler, B., Espin-Garcia, O., Xu, W., Turpin, W., Croitoru, K. & Crohn’s and Colitis Canada Genetics Environment Microbial Project Research Consortium (2025). Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease. Gut microbes, vol. 17, p. 2546998.
  9. Bhérer, C., Grenier, J.-C., Pelletier, J., Boucher, G., Gagnon, G., Goyette, P., Ashton-Beaucage, D., Stevens, C., Battat, R., Bitton, A., Campeau, P. M., Laprise, C., NIDDK IBD Genetics Consortium, Quebec IBD Genetics Consortium , iGenoMed Consortium , Huang, H., Daly, M., Taliun, D., Hussin, J. G., Mooser, V. & Rioux, J. D. (2025). Frequency enrichment of coding variants in a French-Canadian founder population and its implication for inflammatory bowel diseases. medRxiv : the preprint server for health sciences.
  10. Li Fraine, S., Marcus, V., Kron, C. M., Lakatos, P. L., Afif, W., Bitton, A., Wild, G. & Bessissow, T. (2025). Impact of Individual Colonic Segment Histological Activity on Disease Relapse in Patients with Ulcerative Colitis. Journal of clinical medicine, vol. 14.
Voir plus sur PubMed 



Voir aussi

Card image
Peter
Lakatos


Voir le profil
Card image
Waqqas
Afif


Voir le profil
Card image
Talat
Bessissow


Voir le profil
Card image
Paul
Brassard


Voir le profil
Card image
Donald
Vinh


Voir le profil
Card image
Giada
Sebastiani


Voir le profil